Key facts
- Lynx FinHealth’s last known valuation is $98.0M (Feb 2025).
- It has raised $46.5M; the latest was Early Stage VC ($29.0M) in Feb 2025.
- Notable investors include Flare Capital Partners, Obvious Ventures, CVS Health Ventures, McKesson Ventures, .406 Ventures — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Lynx FinHealth
- ·The full record, as it builds
Funding rounds
No funding rounds for Lynx FinHealth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Lynx FinHealth
Developer of a healthcare fintech platform designed to help organizations build and launch digital payments, benefits, and commerce experiences. The company's platform offers API-first and white-label capabilities for banking and ledgering, healthcare payment processing, benefit account management, and integrated e-commerce experiences, enabling health plans, benefit providers, and platforms to deliver unified financial experiences while managing compliance and operational complexity.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2021
- Employees
- 41
- Website
- lynx-fh.com/
- Ownership
- Privately Held (backing)
Lynx FinHealth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Lynx FinHealth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Lynx FinHealth in its N-PORT filings yet. We sweep new filings monthly.